[Skip to Content]
[Skip to Content Landing]
December 18, 1996

Folic Acid Fortification of the Food SupplyPotential Benefits and Risks for the Elderly Population

Author Affiliations

From the Jean Mayer US Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, Mass (Drs Tucker, Jacques, and Selhub and Ms Mahnken), and the Framingham (Mass) Heart Study, National Heart, Lung, and Blood Institute, Bethesda, Md (Dr Wilson).

JAMA. 1996;276(23):1879-1885. doi:10.1001/jama.1996.03540230029031

Objective.  —To estimate the potential benefits and risks of food folic acid fortification for an elderly population. Benefits are expected through the improvement of folate and homocysteine status, but there is also a risk of masking or precipitating clinical manifestations related to vitamin B12 deficiency with increasing exposure to folic acid.

Desing.  —Cross-sectional analysis, with projected change at various levels of folic acid fortification.

Setting.  —Participants in the Framingham Heart Study original cohort.

Participants.  —A total of 747 subjects aged 67 to 96 years who both completed usable food frequency questionnaires and had blood concentrations of B vitamins and homocysteine measured.

Main Outcome Measures.  —Projected blood folate and homocysteine concentrations and combined high folate intake and low plasma vitamin B12 concentration.

Results.  —Percentages of this elderly population with folate intake below 400 μg/d are projected to drop from 66% at baseline to 49% with 140 μg of folate per 100 g of cereal-grain product, to 32% with 280 μg, to 26% with 350 μg, and to 11% with 700 μg. Percentages with elevated homocysteine concentrations (>14 μmol/ L) are projected to drop from 26% at baseline to 21% with 140 μg of folate per 100 g, to 17% with 280 μg, to 16% with 350 μg, and to 12% with 700 μg. Without fortification, the prevalence of combined high folate intake (>1000 μg/d) and low plasma vitamin B12 concentration (<185 pmol/L [<250 pg/mL]) was 0.1%. This is projected to increase to 0.4% with folate fortification levels of 140 to 350 μg/100 g and to 3.4% with 700 μg.

Conclusion.  —The evidence suggests that, at the level of 140 μg/100 g of cereal-grain product mandated by the Food and Drug Administration, the benefits of folate fortification, through projected decreases in homocysteine level and heart disease risk, greatly outweigh the expected risks. However, quantification of the actual risks associated with vitamin B12 deficiency remains elusive. Before higher levels of folic acid fortification are implemented, further research is needed to better understand the clinical course of various forms of vitamin B12 deficiency, to measure the potential effect of high folate intake on this course, and to identify cost-effective approaches to the identification and treatment of all forms of vitamin B12 deficiency.